BRÈVE

sur Viromed Medical AG (isin : DE000A3MQR65)

Viromed Medical AG Explores Major Global Partnership

Viromed Medical AG, a company based in Pinneberg, Germany, is actively seeking a significant collaboration with a major global company within the pharmaceutical sector. This potential partnership would focus on granting Viromed a worldwide license for the medical application of cold atmospheric pressure plasma.

Negotiations are underway, with a contractual agreement anticipated within the next three months. Viromed projects initial revenues in the low double-digit million range by the latter half of 2025, contingent on the agreement's finalization.

The discussions also extend to possible cross-participation between Viromed and the global group’s portfolio companies. Details of such participations remain under negotiation. Viromed commits to updating the market on any progress regarding this cooperation.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Viromed Medical AG